• Chair of UK’s MHRA Leaving

    Sir Gordon Duff, the chairman of the UK Medicines and Healthcare products Regulatory Agency (MHRA) announced on 27 March 2014 that he is giving up his position at the agency after his recent appointment as Principal of St Hilda's College, Oxford. The move is to take place "later this year" and the Department of Health has already initiated a recruitment process to find a successor for Sir Gordon. Prior to taking the position as chair of the MHRA in January 2013, Sir Go...
  • After Decade at MHRA, Breckenridge to Step Aside

    The UK's Medicines and Healthcare products Regulatory Agency (MHRA) will have a new chairman as of 1 January 2013, the agency has announced. Professor Sir Gordon Duff will assume the position of chairman of MHRA on the first of the new year, replacing outgoing Chairman Sir Alasdair Breckenridge, whose term ends on 31 December 2012. The transition is a significant one for MHRA, as Breckenridge has been chairman of the agency since its inception in April 2003. Prior to ...
  • Eli Lilly's Lechleiter Replaces Sanofi's Veibacher as PhRMA Chairman

    • 16 April 2012
    The Pharmaceutical Researchers and Manufactuers of America (PhRMA), the powerful trade organization of the pharmaceutical industry, announced at its annual meeting its members have elected John C. Lechleiter, CEO of Eli Lilly and Co., as its next chairman. Lechleiter will replace outgoing Chairman Christopher Veichbacher, CEO of Sanofi, who has served the organization since 2008. The Chairman of the PhRMA Board-along with PhRMA's President, currently John Castellani-has...